Raj, R., Kumar, A., Prachi Sood, Kumar, R., & Rana, V. (2023). Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel as First Line Treatment in Women with Advanced Breast Cancer. Journal for Research in Applied Sciences and Biotechnology, 2(3), 55–63. https://doi.org/10.55544/jrasb.2.3.8